Gomekli 2 MG capsule 84S
Ended Awarded Last action
- Contract number
- SPE2DR26FM2SX
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $34,650
Award facts
- Contract value 100% obligated
- $34,650.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $34.65K firm fixed-price delivery order to AmerisourceBergen Drug Corp (parent company Cencora, Inc.) on January 20, 2026, for the supply of Gomekli 2 mg capsules (84-count units). This is a non-set-aside, competitively awarded delivery order with an ultimate completion date of February 10, 2026, and performance occurring at the awardee's location in Conshohocken, Pennsylvania. The delivery order is issued under a larger Indefinite Delivery Contract vehicle—the DLA Troop Support Medical Pharmaceutical Prime Vendor Global Program, valued at up to $999.999B through December 2026—which serves as a comprehensive procurement mechanism for supplying pharmaceutical products and medical supplies to support military healthcare systems worldwide.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through the DLA Medical Supply Chain. The company maintains extensive contract authority to deliver a broad range of pharmaceutical products including specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains. This delivery order for Gomekli capsules represents a routine procurement action within the company's established federal contract portfolio, demonstrating continued capability to meet DLA's pharmaceutical supply requirements for military treatment facilities and related federal healthcare institutions.
Quick answers
Who was awarded contract SPE2DR26FM2SX?
SPE2DR26FM2SX was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 20, 2026.
How much is contract SPE2DR26FM2SX worth?
The government has obligated $34,650 on SPE2DR26FM2SX.
Is contract SPE2DR26FM2SX an order under another contract?
Yes. SPE2DR26FM2SX is a delivery order under SPE2DR25D3501, an indefinite delivery contract.
Was contract SPE2DR26FM2SX competed?
The extent of competition for SPE2DR26FM2SX was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award